Jefferies Lifts PT on Integra LifeSciences (IART) to $46
Tweet Send to a Friend
Jefferies bumped its price target on Buy-rated Integra LifeSciences (NASDAQ: IART) from $43 to $46 following Q4 results.
The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE